StockNews.AI
AAPG
StockNews.AI
160 days

Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025

1. Ascentage Pharma to release full year 2024 financial results on March 27, 2025. 2. Conference call and webcast will feature management Q&A sessions for investors. 3. Chinese (Mandarin) investor event scheduled for March 28, 2025. 4. Ascentage focuses on therapies for unmet medical needs in hematological malignancies. 5. AAPG was listed on Nasdaq in January 2025 and HKEX in October 2019.

Earnings
+0.74%Current Return
VS
-0.57%S&P 500
$1903/12 08:49 AM EDTEvent Start
$19.1403/13 03:22 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

Upcoming financial results could reveal growth or challenges, impacting investor sentiment. Historically, earnings announcements can create volatility.

How important is it?

Financial results may significantly influence AAPG's stock price with immediate market reactions expected.

Why Short Term?

The announcement date is very soon, and immediate investor reactions are expected. Previous earnings reports have influenced AAPG's short-term price movements.

Related Companies

HKEX: 6855NASDAQ: AAPG
ROCKVILLE, Md. and SUZHOU, China, March 12, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that it will release full year 2024 financial results, and provide an update on recent developments on March 27, 2025 at 7:00 am Eastern Daylight Time (EDT) / 7:00 pm Hong Kong Time (HKT). Analysts and investors are invited to join a conference call and audio webcast presentation with Q&A, conducted by the Ascentage management team. The English conference call and webcast will be held at 8:00 am EDT / 8:00 pm HKT on March 27, 2025. To access the English conference call, please register in advance here to obtain a local or toll-free phone number and your personal pin.   A live webcast of the English conference call will be available on the Ascentage Pharma website at: Full Year 2024 Financial Results. Ascentage will host a Chinese (Mandarin) investor event at 9:30 am HKT on Friday, March 28, 2025 (9:30 pm EDT on Thursday, March 27, 2025), which will also be available simultaneously via conference call and webcast.  To access the Chinese investor event or conference call, please register in advance here. The webcast replay for both conference calls will also be available on the News & Events page of the Ascentage Pharma website and will be archived for 30 days. About Ascentage Pharma Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies. Ascentage Pharma has been listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code 6855.HK since October 2019 and has also been listed on the Nasdaq Global Market under the ticker symbol “AAPG” since January 2025. Contacts Investor RelationsHogan Wan, Head of IR and StrategyAscentage PharmaHogan.Wan@ascentage.com+86 512 85557777 Stephanie CarringtonICR HealthcareStephanie.Carrington@icrhealthcare.com(646) 277-1282  Media RelationsSean LeousICR HealthcareSean.Leous@icrhealthcare.com(646) 866-4012

Related News